Share

News about the EORTC Liaison Offices in the United Kingdom and in France

This month a new UK-based EORTC Liaison Officer, Liz Flackett (e.flackett[at]ncrn.org.uk), joined the EORTC Liaison Office in the UK. This Office is jointly supported by the EORTC, the National Cancer Research Network (NCRN) and Cancer Research UK (CRUK) has taken her position. In June, a Liaison Office in France will be set up in partnership between the EORTC and the Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC).

These Liaison Offices are aimed at fostering collaborative clinical cancer research between the EORTC and other international cancer research organisations and also supporting EORTC members in order to facilitate administrative and regulatory aspects of conducting EORTC trials.

Back to news list

Related News

  • EORTC shines a light on advancements in radioligand therapy

  • Treatment optimisation: making cancer treatment accessible and sustainable in Europe

  • EORTC celebrates World Radiotherapy Awareness Day (WRAD) through innovation and collaboration in clinical cancer trials

  • 2148 MRD Study reaches milestone with First Patient In (FPI)

  • PET imaging widely used in European brain tumour centres, survey shows

  • New EORTC Leadership: President-Elect and Scientific Chairs Council

  • First Site Activated in EU-Funded DE-ESCALATE Clinical Trial on Advanced Metastatic Prostate Cancer

  • EORTC publishes its 2024 Annual Report: Driving progress in cancer treatment, together

  • EORTC in the spotlight at ASCO 2025

  • EORTC’s presence at ASCO 2025